Cancer is the leading cause of death among people with diabetes in England.
This is the finding of an 18-year-study of over 300,000 people with diabetes in England, from scientists from Imperial College London and published in the journal The L...
Genetically determined vitamin D levels do not have a large effect on risk of type 1 diabetes in Europeans, according to a study published 25th February 2021 in the open-access journal PLOS Medicine by Despoina Manousaki from the CHU Sainte Just...
On April 22, the FDA approved sacituzumab govitecan for the treatment of adult patients with metastatic triple-negative breast cancer who have received at least two prior therapies for metastatic disease. It is a next generation antibody-drug co...
In 2018 and 2019, the German Institute for Quality and Efficiency in Health Care (IQWiG) already investigated whether the drug enzalutamide has an advantage in comparison with the appropriate comparator therapy, i.e. in comparison with watchful ...
LAROTRECTINIB APPROVED FOR SOLID TUMORS WITH NTRK MUTATION
On November 26, 2018, the US Food and Drug Administration (FDA) approved larotrectinib (Vitrakvi; Loxo Oncology), the first drug approved for the treatment of adults and pedia...
For those with extremely high blood pressure, or hypertension, there are many initial medication options — so many that it can be hard to know which one to use.Now, a Yale-coauthored paper in Lancet provides more information about the relative safet...
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and Shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins.PEGyl...
Polyethylene glycol (PEG) is a biocompatible, synthetic, hydrophilic polyether compound that has many applications, mostly in the medical industry, but also in the chemical and industrial sectors.
The synthesis of PEG is done by polymerizing ethylene oxi...